XML 23 R7.htm IDEA: XBRL DOCUMENT v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net income (loss) $ 131,811 $ (25,645)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization 68,723 76,189
Amortization of debt discount and issuance costs 3,120 4,383
Provision for credit losses 3,005 2,390
Stock-based compensation expense 38,846 5,495
Non-cash lease expense 3,998 3,646
Deferred income tax 14,155 (1,479)
Loss on debt extinguishment 7,366 5,264
Contingent consideration revaluation (1,753) 18,300
Post-conversion earnout share liability revaluation (4,091) 1,096
Change in operating assets and liabilities:    
Accounts receivable (25,874) (66,966)
Income tax receivable 321 713
Prepaid expenses and other current assets 4,057 (7,788)
Other assets (2,322) (1,534)
Accounts payable (2,303) 83,534
Accrued liabilities 23,878 21,199
Other current liabilities (1,905) (3,440)
Other long-term liabilities (2,546) 3,255
Net cash provided by operating activities 258,486 118,612
Cash flows from investing activities:    
Purchase and capitalization of property, equipment, and software (41,585) (37,756)
Net cash used in investing activities (41,585) (37,756)
Cash flows from financing activities:    
Proceeds from the exercise of stock options 2,500 1,322
Proceeds from issuance of preferred stock 0 409,545
Proceeds from post-conversion earnout share liability 0 5,393
Proceeds from debt 0 693,686
Proceeds from initial public offering, net of underwriting discounts and commissions 472,397 0
Repurchase of common stock and vested equity awards from stockholders 0 (404,287)
Payment of debt principal (423,074) (439,660)
Payment of debt issuance costs 0 (1,942)
Dividend distribution to stockholders 0 (340,432)
Payment of deferred offering costs (16,374) 0
Net cash provided by (used in) financing activities 35,449 (76,375)
Effect of exchange rate on cash, cash equivalents, and restricted cash (5) 737
Net increase in cash, cash equivalents, and restricted cash 252,345 5,218
Cash, cash equivalents, and restricted cash, beginning of period 134,095 99,088
Cash, cash equivalents, and restricted cash, end of period 386,440 104,306
Components of cash, cash equivalents, and restricted cash    
Cash and cash equivalents 385,651 103,517
Restricted cash 789 789
Total cash, cash equivalents, and restricted cash 386,440 104,306
Supplemental disclosures of cash flow information:    
Cash paid for income taxes, net of income tax refunds received 18,021 11,065
Cash paid for interest 98,309 97,000
Cash paid for amounts included in the measurement of operating lease liabilities 4,589 3,855
Supplemental disclosures of non-cash investing and financing activities:    
Conversion of Series A Redeemable Convertible Preferred Stock to common stock upon initial public offering 414,607 0
Right-of-use assets obtained in exchange for operating lease liabilities, net of modifications 940 8,389
Amounts related to issuance of preferred stock and repurchase of common stock and vested stock-based compensation awards, received and paid through escrow 0 5,062
Unpaid deferred offering costs $ 0 $ 2,603